The Asia Pacific market for PV devices will grow modestly through 2028, fueled by the growing PAD population and the adoption of premium devices. However, lack of reimbursement and cost constraints will limit market growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in the Asia Pacific region across a 10-year period.

Table of contents

  • Peripheral Vascular Devices - Market Insights - Asia Pacific (Supplemental)

Author(s): Bishwjit Ghoshal, MBA

Bishwjit Ghoshal is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.

Follow Bishwjit on twitter: @Bishwjit_DRG


Related Reports

Peripheral Vascular Devices - Market Insights - Canada

The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product la...

View Details

Peripheral Vascular Devices - Market Insights - Latin America

A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in th...

View Details

Peripheral Vascular Devices - Market Insights - Japan

The Japanese PV device market will see modest growth through 2028, driven primarily by the expa...

View Details

Peripheral Vascular Devices - Market Insights - Asia Pacific

The Asia Pacific market for PV devices will grow modestly through 2028, fueled by the growing PAD population and the adoption of premium devices lik...

View Details